These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25037130)

  • 21. CF versus CRMS: diagnostic challenges in cystic fibrosis.
    Temme R; Roggenbuck J; McNamara J
    Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.
    Lee AJ; Huffmyer JL; Thiele EL; Zeitlin PL; Chatterjee D
    Anesth Analg; 2022 Jun; 134(6):1245-1259. PubMed ID: 35020677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CFTR modulator theratyping: Current status, gaps and future directions.
    Clancy JP; Cotton CU; Donaldson SH; Solomon GM; VanDevanter DR; Boyle MP; Gentzsch M; Nick JA; Illek B; Wallenburg JC; Sorscher EJ; Amaral MD; Beekman JM; Naren AP; Bridges RJ; Thomas PJ; Cutting G; Rowe S; Durmowicz AG; Mense M; Boeck KD; Skach W; Penland C; Joseloff E; Bihler H; Mahoney J; Borowitz D; Tuggle KL
    J Cyst Fibros; 2019 Jan; 18(1):22-34. PubMed ID: 29934203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New tests for cystic fibrosis.
    Davies JC
    Paediatr Respir Rev; 2006; 7 Suppl 1():S141-3. PubMed ID: 16798543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
    Lubamba B; Dhooghe B; Noel S; Leal T
    Clin Biochem; 2012 Oct; 45(15):1132-44. PubMed ID: 22698459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of cystic fibrosis in India: What is at stake for developing countries?
    Purushothaman AK; Natarajan S; Panigrahi T; Nelson EJR
    J Biosci; 2024; 49():. PubMed ID: 38920104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A foetus with cystic fibrosis - To treat or not to treat?
    Padmakumar N; Khan HS
    Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis.
    Talwalkar JS; Koff JL; Lee HB; Britto CJ; Mulenos AM; Georgiopoulos AM
    Psychosomatics; 2017; 58(4):343-354. PubMed ID: 28576305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis.
    Fajac I; Burgel PR
    Presse Med; 2023 Sep; 52(3):104169. PubMed ID: 37516246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CFTR Modulators: From Mechanism to Targeted Therapeutics.
    Yeh HI; Sutcliffe KJ; Sheppard DN; Hwang TC
    Handb Exp Pharmacol; 2024; 283():219-247. PubMed ID: 35972584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on new and emerging therapies for cystic fibrosis.
    Hudock KM; Clancy JP
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):331-346. PubMed ID: 29264936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of cystic fibrosis in adulthood and eligibility for novel CFTR modulator therapy.
    Farley H; Poole S; Chapman S; Flight W
    Postgrad Med J; 2022 May; 98(1159):341-345. PubMed ID: 33452147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for cystic fibrosis.
    Amin R; Ratjen F
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):143-55. PubMed ID: 24479826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cystic fibrosis in childhood and adulthood].
    Syunyaeva Z; Mall MA; Stahl M
    Inn Med (Heidelb); 2024 Jun; 65(6):538-544. PubMed ID: 38714556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patients with cystic fibrosis become adults : Treatment hopes and disappointments].
    Eschenhagen P; Schwarz C
    Internist (Berl); 2019 Jan; 60(1):98-108. PubMed ID: 30627755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
    Birault V; Solari R; Hanrahan J; Thomas DY
    Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.